Page number 3
2 Investor presentation First nine months of 2020 AgendAagenda Prog COVI Com Inno Finan
Page number 4
Novo Nordisk® gress on Strategic aspirations 2025 ID-19 update mmercial execution ovation and therapeutic focus ncials
2 Investor presentation First nine months of 2020 AgendAagenda Prog COVI Com Inno Finan
Novo Nordisk® gress on Strategic aspirations 2025 ID-19 update mmercial execution ovation and therapeutic focus ncials
